World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
52
Citations
9936
World Ranking
4059
National Ranking
272

Manfred Zierhut publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Manfred Zierhut sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 309 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Manfred Zierhut D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Manfred Zierhut sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 52 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Manfred Zierhut was affiliated with the University of Tübingen in Germany and focused on medical research, particularly in the field of ophthalmology. Their scholarly contributions spanned a wide range of topics related to ocular diseases, immunology, and related systemic conditions.

Their main field of study was Medicine, with significant specialization in Ophthalmology. Additional subfields included Rheumatology, Epidemiology, Dermatology, and Oncology.

Manfred Zierhut's research addressed several major topics within ophthalmic and systemic conditions:

  • Ocular Diseases and Behçet's Syndrome
  • Retinal and Optic Conditions
  • Cytomegalovirus and Herpesvirus Research
  • Retinal Diseases and Treatments
  • Vasculitis and Related Conditions
  • Systemic Lupus Erythematosus Research
  • Ocular Infections and Treatments

Their work was published predominantly in the following venues:

  • Ocular Immunology and Inflammation
  • British Journal of Ophthalmology
  • Ophthalmology
  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • Indian Journal of Ophthalmology

Among notable recent papers authored or co-authored by Zierhut were:

  • Ocular Adverse Events After COVID-19 Vaccination (2021), published in Ocular Immunology and Inflammation
  • COVID-19 and Immunosuppression: A Review of Current Clinical Experiences and Implications for Ophthalmology Patients Taking Immunosuppressive Drugs (2020), published in British Journal of Ophthalmology
  • COVID-19: Limiting the Risks for Eye Care Professionals (2020), published in Ocular Immunology and Inflammation
  • Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma (2021), published in Ocular Immunology and Inflammation
  • Viral Anterior Uveitis (2020), published in Indian Journal of Ophthalmology

Their frequent collaborators included the following researchers:

  • Emmett T. Cunningham
  • Vishali Gupta
  • Rupesh Agrawal
  • Carlos Pavésio
  • Justine R. Smith

Best Publications

  • The use of interferon α in behçet disease: review of the literature

    Ina Kötter;Ilhan Günaydin;Manfred Zierhut;Nicole Stübiger

  • Behçet's disease: Ocular effects and treatment

    Christoph M E Deuter;Ina Kötter;Graham R Wallace;Philip I Murray

  • Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel

    M. Schaller;L. M.C. Almeida;A. Bewley;B. Cribier

  • High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates

    Irina Bonzheim;Sabrina Giese;Christoph Deuter;Daniela Süsskind

  • Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis

    A. Heiligenhaus;H. Michels;C. Schumacher;I. Kopp

  • Ocular Adverse Events After COVID-19 Vaccination.

    Xin Le Ng;Bjorn Kaijun Betzler;Ilaria Testi;Su Ling Ho

  • Immunology and functional genomics of Behçet's disease.

    M. Zierhut;N. Mizuki;S. Ohno;H. Inoko

  • Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.

    Anjo Riemens;Jacoline Bromberg;Valerie Touitou;Bianka Sobolewska

  • Differential efficacy of human recombinant interferon-α2a on ocular and extraocular manifestations of behçet disease: results of an open 4-center trial

    Ina Kötter;Reinhard Vonthein;Manfred Zierhut;Anja Katrin Eckstein

  • Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.

    Kirsten Siepmann;Matthias Huber;Nicole Stübiger;Christoph Deuter

  • Strengths and weaknesses of diagnostic tools for tuberculous uveitis.

    Daniel V. Vasconcelos-Santos;Manfred Zierhut;Narsing A. Rao

  • Interferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot study

    Christoph M E Deuter;Ina Koetter;Ilhan Guenaydin;Nicole Stuebiger

  • Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases.

    Torsten Schlote;Matthias Derse;Manfred Zierhut

  • Vaccine-Associated Uveitis.

    Emmett T. Cunningham;Ramana S. Moorthy;Frederick W. Fraunfelder;Manfred Zierhut

  • Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

    A Heiligenhaus;K Minden;Christoph Tappeiner;H Baus

  • COVID-19: Limiting the Risks for Eye Care Professionals.

    Soumen Sadhu;Rupesh Agrawal;Rupesh Agrawal;Richa Pyare;Carlos Pavesio

  • Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma

    Denise Carbonell;Sarakshi Mahajan;Soon-Phaik Chee;Bianka Sobolewska

  • Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop

    Rupesh Agrawal;Rupesh Agrawal;Rupesh Agrawal;Aniruddha Agarwal;Douglas A Jabs;Douglas A Jabs;Aera Kee

  • COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.

    Zheng Xian Thng;Marc D De Smet;Cecilia S Lee;Vishali Gupta

  • Viral anterior uveitis.

    Kalpana Babu;Vinaya Kumar Konana;Sudha K Ganesh;Gazal Patnaik

  • Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.

    Treusch M;Vonthein R;Baur M;Günaydin I

  • Tuberculosis or sarcoidosis: Opposite ends of the same disease spectrum?

    Rupesh Agrawal;Rupesh Agrawal;Ae Ra Kee;Leslie Ang;Yeo Tun Hang

  • Mycophenolate mofetil (MMF) is a highly effective and safe immunosuppressive agent for the treatment of uveitis

    M. Zierhut;M. Huber;N. Stuebiger;C. Deuter

Frequent Co-Authors

Martin Schaller
Martin Schaller University of Tübingen
Hans-Georg Rammensee
Hans-Georg Rammensee University of Tübingen
Lothar Kanz
Lothar Kanz University of Tübingen
Janet L. Davis
Janet L. Davis University of Miami
Jennifer E. Thorne
Jennifer E. Thorne Johns Hopkins University
Denis Wakefield
Denis Wakefield University of New South Wales
John V. Forrester
John V. Forrester University of Aberdeen
Andrew D. Dick
Andrew D. Dick University of Bristol
James T. Rosenbaum
James T. Rosenbaum Oregon Health & Science University
Shigeaki Ohno
Shigeaki Ohno Hokkaido University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career avenues. Many professionals transition into clinical roles that align with immunological knowledge, such as nursing and patient care. Online education has made these pathways more accessible, offering flexible options tailored for different backgrounds.

If you’re coming from a non-nursing background but want to enter healthcare, online BSN programs for non nurses provide a direct route to becoming a registered nurse through specialized curriculum designed for career changers.

For faster entry into nursing, consider 12-month accelerated nursing programs, which compress key training into a shorter timeframe without compromising quality. These are ideal for motivated individuals seeking rapid progress.

Specific to family health, pursuing an accelerated FNP program can prepare you for advanced practice roles, integrating immunology principles with patient-centered care.

For entry-level nursing roles, exploring LPN schools easy to get into can help you start your healthcare journey quickly while gaining clinical experience relevant to immunology settings.

Best Scientists Citing Manfred Zierhut

Recently Published Articles